148 related articles for article (PubMed ID: 20152808)
1. An antiviral disulfide compound blocks interaction between arenavirus Z protein and cellular promyelocytic leukemia protein.
García CC; Topisirovic I; Djavani M; Borden KL; Damonte EB; Salvato MS
Biochem Biophys Res Commun; 2010 Mar; 393(4):625-30. PubMed ID: 20152808
[TBL] [Abstract][Full Text] [Related]
2. Arenavirus Z protein as an antiviral target: virus inactivation and protein oligomerization by zinc finger-reactive compounds.
García CC; Djavani M; Topisirovic I; Borden KLB; Salvato MS; Damonte EB
J Gen Virol; 2006 May; 87(Pt 5):1217-1228. PubMed ID: 16603524
[TBL] [Abstract][Full Text] [Related]
3. An arenavirus RING (zinc-binding) protein binds the oncoprotein promyelocyte leukemia protein (PML) and relocates PML nuclear bodies to the cytoplasm.
Borden KL; Campbell Dwyer EJ; Salvato MS
J Virol; 1998 Jan; 72(1):758-66. PubMed ID: 9420283
[TBL] [Abstract][Full Text] [Related]
4. Two RING finger proteins, the oncoprotein PML and the arenavirus Z protein, colocalize with the nuclear fraction of the ribosomal P proteins.
Borden KL; Campbelldwyer EJ; Carlile GW; Djavani M; Salvato MS
J Virol; 1998 May; 72(5):3819-26. PubMed ID: 9557665
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of different Lassa virus strains by alpha and gamma interferons and comparison with a less pathogenic arenavirus.
Asper M; Sternsdorf T; Hass M; Drosten C; Rhode A; Schmitz H; Günther S
J Virol; 2004 Mar; 78(6):3162-9. PubMed ID: 14990737
[TBL] [Abstract][Full Text] [Related]
6. The RING domains of the promyelocytic leukemia protein PML and the arenaviral protein Z repress translation by directly inhibiting translation initiation factor eIF4E.
Kentsis A; Dwyer EC; Perez JM; Sharma M; Chen A; Pan ZQ; Borden KL
J Mol Biol; 2001 Sep; 312(4):609-23. PubMed ID: 11575918
[TBL] [Abstract][Full Text] [Related]
7. Role of the promyelocytic leukemia protein PML in the interferon sensitivity of lymphocytic choriomeningitis virus.
Djavani M; Rodas J; Lukashevich IS; Horejsh D; Pandolfi PP; Borden KL; Salvato MS
J Virol; 2001 Jul; 75(13):6204-8. PubMed ID: 11390623
[TBL] [Abstract][Full Text] [Related]
8. Cellular proteins PML and Daxx mediate an innate antiviral defense antagonized by the adenovirus E4 ORF3 protein.
Ullman AJ; Hearing P
J Virol; 2008 Aug; 82(15):7325-35. PubMed ID: 18480450
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Junín virus particles inactivated by a zinc finger-reactive compound.
García CC; Ellenberg PC; Artuso MC; Scolaro LA; Damonte EB
Virus Res; 2009 Jul; 143(1):106-13. PubMed ID: 19463727
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus core protein inhibits tumor suppressor protein promyelocytic leukemia function in human hepatoma cells.
Herzer K; Weyer S; Krammer PH; Galle PR; Hofmann TG
Cancer Res; 2005 Dec; 65(23):10830-7. PubMed ID: 16322229
[TBL] [Abstract][Full Text] [Related]
11. Cells expressing the RING finger Z protein are resistant to arenavirus infection.
Cornu TI; Feldmann H; de la Torre JC
J Virol; 2004 Mar; 78(6):2979-83. PubMed ID: 14990716
[TBL] [Abstract][Full Text] [Related]
12. Characterization of Recombinant Human Cytomegaloviruses Encoding IE1 Mutants L174P and 1-382 Reveals that Viral Targeting of PML Bodies Perturbs both Intrinsic and Innate Immune Responses.
Scherer M; Otto V; Stump JD; Klingl S; Müller R; Reuter N; Muller YA; Sticht H; Stamminger T
J Virol; 2016 Feb; 90(3):1190-205. PubMed ID: 26559840
[TBL] [Abstract][Full Text] [Related]
13. Effects of promyelocytic leukemia protein on virus-host balance.
Bonilla WV; Pinschewer DD; Klenerman P; Rousson V; Gaboli M; Pandolfi PP; Zinkernagel RM; Salvato MS; Hengartner H
J Virol; 2002 Apr; 76(8):3810-8. PubMed ID: 11907221
[TBL] [Abstract][Full Text] [Related]
14. ZNF198, a zinc finger protein rearranged in myeloproliferative disease, localizes to the PML nuclear bodies and interacts with SUMO-1 and PML.
Kunapuli P; Kasyapa CS; Chin SF; Caldas C; Cowell JK
Exp Cell Res; 2006 Nov; 312(19):3739-51. PubMed ID: 17027752
[TBL] [Abstract][Full Text] [Related]
15. Role of SUMO in RNF4-mediated promyelocytic leukemia protein (PML) degradation: sumoylation of PML and phospho-switch control of its SUMO binding domain dissected in living cells.
Percherancier Y; Germain-Desprez D; Galisson F; Mascle XH; Dianoux L; Estephan P; Chelbi-Alix MK; Aubry M
J Biol Chem; 2009 Jun; 284(24):16595-16608. PubMed ID: 19380586
[TBL] [Abstract][Full Text] [Related]
16. Functional interactions between the Epstein-Barr virus BZLF1 protein and the promyelocytic leukemia protein.
Bowling BL; Adamson AL
Virus Res; 2006 May; 117(2):244-53. PubMed ID: 16307818
[TBL] [Abstract][Full Text] [Related]
17. The lymphocytic choriomeningitis virus RING protein Z associates with eukaryotic initiation factor 4E and selectively represses translation in a RING-dependent manner.
Campbell Dwyer EJ; Lai H; MacDonald RC; Salvato MS; Borden KL
J Virol; 2000 Apr; 74(7):3293-300. PubMed ID: 10708446
[TBL] [Abstract][Full Text] [Related]
18. The major immediate-early proteins IE1 and IE2 of human cytomegalovirus colocalize with and disrupt PML-associated nuclear bodies at very early times in infected permissive cells.
Ahn JH; Hayward GS
J Virol; 1997 Jun; 71(6):4599-613. PubMed ID: 9151854
[TBL] [Abstract][Full Text] [Related]
19. Epstein-barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies.
Adamson AL; Kenney S
J Virol; 2001 Mar; 75(5):2388-99. PubMed ID: 11160742
[TBL] [Abstract][Full Text] [Related]
20. Role of SUMO-1-modified PML in nuclear body formation.
Zhong S; Müller S; Ronchetti S; Freemont PS; Dejean A; Pandolfi PP
Blood; 2000 May; 95(9):2748-52. PubMed ID: 10779416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
